Reference
Lin B, et al. Combination of Anlotinib and Gefitinib in the Treatment of EGFR Mutation NSCLC Causing Severe Subcutaneous Hemorrhage: A Case Report. [Chinese]. Anti-Tumor Pharmacy 9: 527-528, No. 3, Jun 2019. Available from: URL: http://caod.oriprobe.com/articles/56923369/an_luo_ti_ni_lian_he_ji_fei_ti_ni_zhi_liao_egfr_tu.htm [Chinese; summarised from a translation] - China
Rights and permissions
About this article
Cite this article
Anlotinib/gefitinib interaction. Reactions Weekly 1772, 36 (2019). https://doi.org/10.1007/s40278-019-68163-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-68163-x